Cooper Companies vs Abbott Laboratories vs Baxter International and 1 More Revenue Comparison
Compare financial metrics side-by-side using real SEC EDGAR data
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Cooper Companies 1.081, Abbott Laboratories 12.593, Baxter International 2.96, Becton Dickinson 4.983.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Cooper Companies, Abbott Laboratories, Baxter International, Becton Dickinson.| Metric | Cooper Companies | Abbott Laboratories | Baxter International | Becton Dickinson |
|---|---|---|---|---|
| Market Cap | $14.17B | $197.44B | $13.70B | $51.81B |
| Revenue | $1.08B | $12.59B | $2.96B | $4.98B |
| Cost of Revenue | $346.00M | $5.29B | $1.93B | $2.67B |
| Gross Profit | $735.00M | $7.30B | $1.03B | $2.31B |
| Operating Income | $-31.00M | $1.78B | $217.00M | $663.00M |
| Net Income | $-78.00M | $928.00M | $126.00M | $377.00M |
| R&D Expense | $43.00M | $882.00M | $129.00M | $258.00M |
| Earnings Per Share | -$0.4 | $0.53 | $0.24 | $1.37 |
| Gross Margin | 68.0% | 58.0% | 34.9% | 46.5% |
| Operating Margin | -2.9% | 14.2% | 7.3% | 13.3% |
| Net Profit Margin | -7.2% | 7.4% | 4.3% | 7.6% |
| Free Cash Flow | $96.00M | $2.89B | $32.00M | $509.00M |
| Cumulative Free Cash Flow | $5.46B | $142.48B | $35.82B | $39.60B |
| Operating Cash Flow | $183.00M | $2.49B | $285.00M | $652.00M |
| Cash & Equivalents | $139.00M | $5.10B | $2.15B | $708.00M |